Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04275882Completed

Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy

Role: lead

NCT03727984Completed

Re-hospitalized Patients With Acute Coronary Syndrome

Role: lead

NCT03601013Completed

Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey

Role: lead

NCT02480920Completed

Adherence to New Oral Anticoagulation Therapy in Turkey

Role: lead

NCT03364387Completed

Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population

Role: lead

All 5 trials loaded